Cargando…

Apremilast in Psoriasis Patients With Serious Comorbidities: a Case Series and Systematic Review of Literature

INTRODUCTION: Patients with serious comorbidities are traditionally excluded from clinical trials. Apremilast is not contraindicated in active infections, malignancy and serious hepatic or renal impairment, but real-life data is needed to support this recommendation. OBJECTIVES: The aim of this pape...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsentemeidou, Aikaterini, Sotiriou, Elena, Sideris, Nikolaos, Bakirtzi, Katerina, Papadimitriou, Ilias, Lallas, Aimilios, Ioannides, Dimitrios, Vakirlis, Efstratios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681161/ https://www.ncbi.nlm.nih.gov/pubmed/36534526 http://dx.doi.org/10.5826/dpc.1204a179

Ejemplares similares

Apremilast Survival and Reasons for Discontinuation in Psoriasis: Five-Year Experience From a Greek Tertiary Care Centre
por: Sotiriou, Elena, et al.
Publicado: (2022)

Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis
por: Tsentemeidou, Aikaterini, et al.
Publicado: (2022)

Sebaceous Neoplasms
por: Papadimitriou, Ilias, et al.
Publicado: (2023)

New and Upcoming Topical Treatments for Atopic Dermatitis: A Review of the Literature
por: Sideris, Nikolaos, et al.
Publicado: (2022)

Photodynamic Therapy for Field Cancerization in the Skin: Where Do We Stand?
por: Bakirtzi, Katerina, et al.
Publicado: (2023)

Under Development JAK Inhibitors for Dermatologic Diseases
por: Sideris, Nikolaos, et al.
Publicado: (2020)

Scabies escaping detection until dermoscopy was applied
por: Lallas, Aimilios, et al.
Publicado: (2017)

Dermoscopic hemorrhagic dots: an early predictor of response of psoriasis to biologic agents
por: Lallas, Aimilios, et al.
Publicado: (2016)

Atypical case of lichen planus recognized by dermoscopy
por: Papageorgiou, Chrysoula, et al.
Publicado: (2016)

Delayed skin cancer diagnosis in 2020 because of the COVID-19–related restrictions: Data from an institutional registry
por: Lallas, Aimilios, et al.
Publicado: (2021)

A retrospective epidemiological study of skin diseases among pediatric population attending a tertiary dermatology referral center in Northern Greece
por: Vakirlis, Efstratios, et al.
Publicado: (2017)

Spotlight on vismodegib in the treatment of basal cell carcinoma: an evidence-based review of its place in therapy
por: Apalla, Zoe, et al.
Publicado: (2017)

Re-Evaluating Limitations in Atopic Dermatitis Meta-Analysis Is Important in Interpreting its Results: Limitations of Atopic Dermatitis meta-analysis
por: Vakirlis, Efstratios, et al.
Publicado: (2021)

Rosacea and Helicobacter pylori: links and risks
por: Lazaridou, Elizabeth, et al.
Publicado: (2017)

Treatment Options and Post-Treatment Malignant Transformation Rate of Actinic Cheilitis: A Systematic Review
por: Bakirtzi, Katerina, et al.
Publicado: (2021)

Clinicopathologically problematic melanocytic tumors: a case-based review
por: Apalla, Zoe, et al.
Publicado: (2018)

Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
por: Vakirlis, Efstratios, et al.
Publicado: (2008)

Melanoma: Staging and Follow-Up
por: Papageorgiou, Chryssoula, et al.
Publicado: (2021)

Modification of Apremilast from Pills to Aerosol a Future Concept
por: Zarogoulidis, Paul, et al.
Publicado: (2021)

Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa
por: Fotiadou, Christina, et al.
Publicado: (2016)

Epidemiological trends in skin cancer
por: Apalla, Zoe, et al.
Publicado: (2017)

Generalized pustular psoriasis treated with apremilast in a patient with multiple medical comorbidities
por: Jeon, Caleb, et al.
Publicado: (2017)

Pediatric psoriasis treated with apremilast
por: Smith, Rebecca L.
Publicado: (2016)

Erythrodermic Psoriasis Treated with Apremilast
por: Arcilla, John, et al.
Publicado: (2016)

Treatment of erythrodermic psoriasis with apremilast
por: Gioe, Olivia A., et al.
Publicado: (2021)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021)

Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors
por: Schmidt, Lana, et al.
Publicado: (2023)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Apremilast or Methotrexate: The Arrows in the Quiver for Psoriasis
por: Panda, Gautam, et al.
Publicado: (2023)

Successful Treatment of Refractory Palmoplantar Pustular Psoriasis With Apremilast: A Case Series
por: Ständer, Sascha, et al.
Publicado: (2020)

Characteristics of Patients with Psoriasis Treated with Apremilast in the Corrona Psoriasis Registry
por: Gottlieb, Alice B., et al.
Publicado: (2021)

Apremilast Improves Endothelial Glycocalyx Integrity, Vascular and Left Ventricular Myocardial Function in Psoriasis
por: Ikonomidis, Ignatios, et al.
Publicado: (2022)

Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast
por: Gooderham, Melinda, et al.
Publicado: (2015)

Recurrence of Melanoma after Starting Apremilast for Psoriasis
por: Salopek, Thomas G.
Publicado: (2017)

Commentary: Successful treatment of refractory palmoplantar pustular psoriasis with apremilast: a case series
por: Hackley, Madison, et al.
Publicado: (2023)

Comorbid psoriasis-bipolar disorder successfully treated with apremilast: much more than a mere coincidence?
por: Uvais, N A, et al.
Publicado: (2020)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer, Stephan, et al.
Publicado: (2015)

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis
por: Gisondi, Paolo, et al.
Publicado: (2016)

Recurrent generalized pustular psoriasis possibly triggered by apremilast
por: Wang, Wen-Ming, et al.
Publicado: (2020)

A case of erythrodermic psoriasis successfully treated with apremilast
por: Megna, Matteo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_31v1687a524ag7u5q7k2ce4hum